Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways

Zamza Khairullina1, Saulesh Kurmangaliyeva1, Rustam Yussupov2

  • 1Department of Microbiology, Virology and Immunology, West Kazakhstan Marat Ospanov Medical University, 68 Maresyev St., Aktobe 030000, Kazakhstan.

Insights

Pesticide exposure contributes to liver diseases by triggering specific cell death pathways. Understanding these mechanisms, including ferroptosis, necroptosis, and pyroptosis, can help prevent liver damage.

Area of Science:

  • Environmental Toxicology
  • Hepatology
  • Cell Biology

Background:

  • Pesticide exposure is linked to various human diseases.
  • The liver is crucial for pesticide detoxification, making it susceptible to pesticide-induced damage.
  • Pesticides contribute to liver conditions like NAFLD, ALD, cirrhosis, and cancer.

Purpose of the Study:

  • To systematically review the role of non-apoptotic regulated cell death (RCD) pathways in pesticide-induced liver toxicity.
  • To highlight ferroptosis, necroptosis, and pyroptosis as underappreciated mechanisms of pesticide-induced liver damage.
  • To explore how these RCDs contribute to liver steatosis, fibrosis, and inflammation.

Main Methods:

  • Systematic review of existing literature on pesticide exposure and liver disease.
  • Analysis of studies investigating pesticide-induced cell death mechanisms.
  • Examination of the link between non-apoptotic RCDs and liver pathology markers.

Main Results:

  • Pesticides induce liver diseases by activating ferroptosis, necroptosis, and pyroptosis.
  • Non-apoptotic RCDs are key mediators of pesticide-induced liver steatosis and fibrosis.
  • These cell death pathways promote inflammation via cytokine production and DAMPs release.

Conclusions:

  • Pesticide-induced liver toxicity involves non-apoptotic regulated cell death pathways.
  • Targeting ferroptosis, necroptosis, and pyroptosis may offer novel strategies for preventing pesticide-related liver damage.
  • Further understanding of RCDs and immunogenic effects is crucial for developing preventive measures.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
11.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
3.5K